214 related articles for article (PubMed ID: 36192747)
1. VHHs as tools for therapeutic protein delivery to the central nervous system.
Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M
Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747
[TBL] [Abstract][Full Text] [Related]
2. Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
Su S; Esparza TJ; Brody DL
PLoS One; 2022; 17(10):e0276107. PubMed ID: 36256604
[TBL] [Abstract][Full Text] [Related]
3. Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics.
Rué L; Jaspers T; Degors IMS; Noppen S; Schols D; De Strooper B; Dewilde M
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376196
[TBL] [Abstract][Full Text] [Related]
4. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates.
Yu YJ; Atwal JK; Zhang Y; Tong RK; Wildsmith KR; Tan C; Bien-Ly N; Hersom M; Maloney JA; Meilandt WJ; Bumbaca D; Gadkar K; Hoyte K; Luk W; Lu Y; Ernst JA; Scearce-Levie K; Couch JA; Dennis MS; Watts RJ
Sci Transl Med; 2014 Nov; 6(261):261ra154. PubMed ID: 25378646
[TBL] [Abstract][Full Text] [Related]
6. Identification and in vivo characterization of a brain-penetrating nanobody.
Wouters Y; Jaspers T; De Strooper B; Dewilde M
Fluids Barriers CNS; 2020 Oct; 17(1):62. PubMed ID: 33054787
[TBL] [Abstract][Full Text] [Related]
7. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys.
Kariolis MS; Wells RC; Getz JA; Kwan W; Mahon CS; Tong R; Kim DJ; Srivastava A; Bedard C; Henne KR; Giese T; Assimon VA; Chen X; Zhang Y; Solanoy H; Jenkins K; Sanchez PE; Kane L; Miyamoto T; Chew KS; Pizzo ME; Liang N; Calvert MEK; DeVos SL; Baskaran S; Hall S; Sweeney ZK; Thorne RG; Watts RJ; Dennis MS; Silverman AP; Zuchero YJY
Sci Transl Med; 2020 May; 12(545):. PubMed ID: 32461332
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model.
Marino M; Zhou L; Rincon MY; Callaerts-Vegh Z; Verhaert J; Wahis J; Creemers E; Yshii L; Wierda K; Saito T; Marneffe C; Voytyuk I; Wouters Y; Dewilde M; Duqué SI; Vincke C; Levites Y; Golde TE; Saido TC; Muyldermans S; Liston A; De Strooper B; Holt MG
EMBO Mol Med; 2022 Apr; 14(4):e09824. PubMed ID: 35352880
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants.
Bien-Ly N; Yu YJ; Bumbaca D; Elstrott J; Boswell CA; Zhang Y; Luk W; Lu Y; Dennis MS; Weimer RM; Chung I; Watts RJ
J Exp Med; 2014 Feb; 211(2):233-44. PubMed ID: 24470444
[TBL] [Abstract][Full Text] [Related]
10. Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain.
Sato S; Liu S; Goto A; Yoneyama T; Okita K; Yamamoto S; Hirabayashi H; Iwasaki S; Kusuhara H
J Control Release; 2023 May; 357():379-393. PubMed ID: 37031741
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody.
Esparza TJ; Su S; Francescutti CM; Rodionova E; Kim JH; Brody DL
Fluids Barriers CNS; 2023 Aug; 20(1):64. PubMed ID: 37620930
[TBL] [Abstract][Full Text] [Related]
12. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.
Yu YJ; Zhang Y; Kenrick M; Hoyte K; Luk W; Lu Y; Atwal J; Elliott JM; Prabhu S; Watts RJ; Dennis MS
Sci Transl Med; 2011 May; 3(84):84ra44. PubMed ID: 21613623
[TBL] [Abstract][Full Text] [Related]
13. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
[TBL] [Abstract][Full Text] [Related]
14. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
[TBL] [Abstract][Full Text] [Related]
15. Passive and receptor mediated brain delivery of an anti-GFAP nanobody.
Meier SR; Sehlin D; Syvänen S
Nucl Med Biol; 2022; 114-115():121-127. PubMed ID: 35487832
[TBL] [Abstract][Full Text] [Related]
16. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
17. Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain.
Kanodia JS; Gadkar K; Bumbaca D; Zhang Y; Tong RK; Luk W; Hoyte K; Lu Y; Wildsmith KR; Couch JA; Watts RJ; Dennis MS; Ernst JA; Scearce-Levie K; Atwal JK; Ramanujan S; Joseph S
CPT Pharmacometrics Syst Pharmacol; 2016 May; 5(5):283-91. PubMed ID: 27299941
[TBL] [Abstract][Full Text] [Related]
18. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging.
Li T; Bourgeois JP; Celli S; Glacial F; Le Sourd AM; Mecheri S; Weksler B; Romero I; Couraud PO; Rougeon F; Lafaye P
FASEB J; 2012 Oct; 26(10):3969-79. PubMed ID: 22730440
[TBL] [Abstract][Full Text] [Related]
20. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
